Published in:
01-10-2021 | EDITORIAL
Doppler Endoscopic Probe-Guided Treatment of Dieulafoy’s Bleeding: Hearing Is Believing
Published in: Digestive Diseases and Sciences | Issue 10/2021
Login to get accessExcerpt
Severe upper gastrointestinal hemorrhage (SUGIH) is one of the most common reasons for inpatient gastroenterology consults in the intensive care unit. Although peptic ulcer disease is the most commonly encountered pathology, Dieulafoy’s lesions (DL) have been reported as the cause in about 1–2% of upper GI bleeding, with some studies reporting rates up to 10% [1]. The key to endoscopic hemostasis of a DL is its visualization and accurate localization, both of which can be near impossible in the absence of active bleeding. Although a recently bled DL does not leave any mucosal ulceration, an actively bleeding DL can be difficult to localize in the presence of pooled blood and/or clots. …Tweet: Largest cohort study demonstrated superior 30-day rebleeding with Doppler monitoring of severe upper GI hemorrhage from Dieulafoy’s lesions as compared with visually guided treatment, limited by small sample and non-randomized, non-controlled study cohorts.